Cascinu, Stefano <br/><br/>
Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.  [electronic resource] 

 -  Journal of the National Cancer Institute  Apr 2007 
 - 601-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1460-2105 
<br/><br/><label>Standard No.: </label>10.1093/jnci/djk131  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Chemotherapy, Adjuvant<br/>Cisplatin--administration & dosage<br/>Disease-Free Survival<br/>Drug Administration Schedule<br/>Epirubicin--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Leucovorin--administration & dosage<br/>Lymphatic Metastasis<br/>Male<br/>Middle Aged<br/>Neoplasm Invasiveness<br/>Stomach Neoplasms--drug therapy<br/>Survival Analysis